Rhumbline Advisers Astellas Pharma Inc Unsponsore Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Astellas Pharma Inc Unsponsore stock. As of the latest transaction made, Rhumbline Advisers holds 31,138 shares of ALPMY stock, worth $357,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,138
Previous 33,873
8.07%
Holding current value
$357,464
Previous $327,000
7.34%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALPMY
# of Institutions
8Shares Held
250KCall Options Held
0Put Options Held
0-
Hantz Financial Services, Inc.165KShares$1.9 Million0.03% of portfolio
-
Nbc Securities, Inc. Birmingham, AL44.5KShares$511,3420.04% of portfolio
-
Gamma Investing LLC Foster City, CA7.17KShares$82,3340.0% of portfolio
-
Private Capital Group, LLC1.09KShares$12,4670.01% of portfolio
-
Wealth Preservation Advisors, LLC Chattanooga, TN224Shares$2,5710.0% of portfolio
About Astellas Pharma Inc Unsponsore
- Ticker ALPMY
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,827,069,952
- Market Cap $21B